Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

CBUS

+ Watchlist+ Portfolio

Cibus, Inc.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Previous Close
$1.70
52-Week Range
$1.09 – $4.19
Market Cap
$129.93M
P/E (TTM)
EPS (TTM)
-1.51
Dividend Yield
Advanced Metrics
Price/Book
3.66
PEG Ratio
Return on Equity
-223.16%
Return on Assets
-10.22%
Gross Margin
100.00%
Operating Margin
-1300.30%
Profit Margin
0.00%
Current Ratio
1.62
Debt/Equity
19.34
Total Debt
$286.26M
Free Cash Flow
$-52.46M
Revenue Growth
6.50%
Earnings Growth
Enterprise Value
$395.76M

Market Snapshot

About

Cibus, Inc. is an agricultural biotechnology company focused on developing and commercializing crop traits using its proprietary gene-editing technology platform. Headquartered in San Diego, California, the company specializes in precision breeding solutions that enhance crop productivity, quality, and sustainability without introducing foreign DNA into plants. Cibus's technology enables targeted modifications to plant genomes, creating improved varieties with traits such as herbicide tolerance, disease resistance, and enhanced nutritional profiles. The company's product pipeline includes trait developments for major row crops including canola, rice, soybeans, and wheat. Cibus works with seed companies and agricultural firms to integrate its traits into commercial seed products distributed to farmers. The company's approach addresses growing global demand for agricultural innovation to increase food production while reducing environmental impact. Cibus operates in the competitive agricultural biotechnology sector, where regulatory approvals, farmer adoption, and commercialization partnerships are critical to success.